As the Director of Biology at Recursion, Sadie Ingle is at the forefront of innovative drug discovery, harnessing the power of advanced biochemistry and machine learning to revolutionize precision oncology. With a robust background in molecular biology and extensive experience in assay development, Sadie leads...
As the Director of Biology at Recursion, Sadie Ingle is at the forefront of innovative drug discovery, harnessing the power of advanced biochemistry and machine learning to revolutionize precision oncology. With a robust background in molecular biology and extensive experience in assay development, Sadie leads the Inferential Search collaboration with Bayer, a groundbreaking initiative aimed at redefining how we approach drug discovery. This partnership leverages Recursion's comprehensive Maps of human biology, integrating automated workflows and sophisticated machine learning models to expedite the identification of novel therapeutic candidates.
Sadie’s expertise in biochemistry is complemented by her hands-on skills in techniques such as Western blotting, microscopy, and protein purification, which are essential for validating biological hypotheses and ensuring the robustness of experimental data. Her proficiency in confocal and fluorescence microscopy enhances her ability to visualize complex biological processes, providing critical insights that drive the strategic direction of early discovery projects.
In her role, Sadie is not only a project leader but also an effective project manager, adept at fostering collaboration among diverse teams. She is passionate about creating an inclusive environment where innovative ideas can flourish, ultimately aiming to tackle some of the most pressing scientific challenges in healthcare. By focusing on the intersection of biology and technology, Sadie is committed to radically improving patient lives through the discovery of transformative medicines, embodying the spirit of innovation that defines Recursion’s mission.
